Publications by authors named "B Van Harten"
Article Synopsis
- Researchers found that Parkinson's disease patients often don't get referred quickly to special centers for treatment using special devices.
- They created a new screening tool to help doctors decide when to refer these patients, and tested it against an existing method called the 5-2-1 criteria.
- The new tool was found to be better at identifying patients who need treatment and seems really effective, but it still needs to be tested further.
Objectives: Neurodegeneration in suspected Alzheimer's disease can be determined using visual rating or quantitative volumetric assessments. We examined the feasibility of volumetric measurements of gray matter (GMV) and hippocampal volume (HCV) and compared their diagnostic performance with visual rating scales in academic and non-academic memory clinics.
Materials And Methods: We included 231 patients attending local memory clinics (LMC) in the Netherlands and 501 of the academic Amsterdam Dementia Cohort (ADC).
Background: Visual hallucinations are common in patients with Parkinson's disease and represent probably the major independent predictor for cognitive deterioration and nursing home placement.
Objective: To investigate if treatment of minor visual hallucinations in Parkinson's disease with rivastigmine delays the progression to psychosis.
Methods: A multicenter, randomized, double-blind, placebo-controlled trial was conducted which aimed to recruit 168 patients with Parkinson's disease reporting minor visual hallucinations 4 weeks before it.
["I can't complete my payment form anymore" : Visual disorders in posterior cortical atrophy].
Tijdschr Gerontol Geriatr
September 2018
Visual problems occur frequently in elderly patients and are often caused by ophthalmological problems. In this clinical lesson we show that visual problems can also be caused by posterior cortical atrophy (PCA). PCA is a clinico-radiological syndrome that is often caused by Alzheimer's disease and other neurodegenerative diseases as Lewy body dementia and corticobasal degeneration.
View Article and Find Full Text PDF